Asthma is increasingly recognised as a heterogeneous disease, with several phenotypes defined by clinical and inflammatory characteristics. Common phenotypes include allergic (eosinophilic, IgE-mediated), non-allergic (often neutrophilic or paucigranulocytic), late-onset adult asthma, obesity-associated asthma, and asthma with persistent airflow limitation.14 Identifying phenotypes supports individualised treatment strategies, particularly in those with severe asthma, and better long-term outcomes.
Steps 2 and 3: Maintenance and reliever therapy (MART)
Comorbid conditions can complicate asthma management. Assess for and help address factors such as allergic rhinitis, which affects up to 80% of people with asthma,24 as well as gastro-oesophageal reflux disease (GORD), anxiety, depression, obstructive sleep apnoea and smoking.
Pharmacist with history of anaphylaxis gets COVID-19 vaccine
Pharmacist immuniser Vanessa Lange MPS has a history of anaphylactic reactions to vaccines. She spoke with Australian Pharmacist about her decision to get the COVID-19 vaccine and using her experience to help vaccine-hesitant patients.
The legal requirements you need to meet for working with children
From Working with Children Checks to the presence of guardians, here's how to provide safe and appropriate services to children.
Helping prevent RSV
Respiratory syncytial virus (RSV) is a common disease that causes cold-like symptoms. Here's how pharmacists can help to protect patients.
Belladonna: beautiful but deadly
Before it helped make a fashion statement, belladonna was used as an anaesthetic, pain reliever and remedy for assorted ailments.
New burns care tool for pharmacists
New national burns resource supports frontline assessment, management and prompt referral of burn injuries.
Public health leaders receive Queen’s Birthday honours
Pharmacists and public health leaders were honoured for their services to the community in this year’s Queen’s Birthday honours.
